Benjamin Ormseth

Benjamin Ormseth

Auto-generated profile, based on publicly available information

Benjamin Ormseth

Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in The Journal of Knee Surgery
Verified
Journal Article
Closed access
PDF file
JSJustine G. Schneider
Justine G. Schneider
BOBenjamin Ormseth
Benjamin Ormseth
ADAlex C. DiBartola
Alex C. DiBartola
RMRobert A. Magnussen
Robert A. Magnussen
RDRobert A. Duerr
Robert A. Duerr
DFDavid C. Flanigan
David C. Flanigan
We sought to assess the current literature to present a comprehensive summary of the incidence, common pathogens, and risk factors for infection after anterior cruciate ligament (ACL) reconstruction. PubMed, CINAHL, EMBASE, and Scopus databases were searched for relevant studies reporting on infection after ACL reconstruction. Two reviewers independently screened the extracted studies for adherence to inclusion and exclusion criteria. Studies were selected if they reported on the incidence of infection, pathogens cultured from infected knees, or risk factors for infection after primary ACL reconstruction. Exclusion criteria consisted of studies with fewer than 100 patients or studies that included revision ACL reconstruction. Fifty studies met the inclusion and exclusion criteria, reporting on a total of 316,214 ACL reconstructions. Included studies evaluated between 123 and 104,255 patients. The overall incidence of infection was 0.60% (0.15–2.44%). The most common pathogens were Staphylococcus aureus, S. epidermidis, and coagulase-negative Staphylococci. Five studies reported that the use of hamstring autograft was a statistically significant risk factor for infection after ACL reconstruction, thus making hamstring autograft the most commonly reported risk factor. Other reported risk factors included male sex, use of immuno-suppressive medications or intraarticular steroid injections, prior knee surgery, and diabetes. Systematic review of the literature revealed that infection after ACL reconstruction remains an infrequent event with an incidence of 0.60% (0.15–2.44%). Furthermore, the most common pathogens are from the Staphylococcus genus of bacteria, comprising 84% of all culture-positive infections. Multiple risk factors have been reported for ACL reconstruction; however, statistical significance varied across studies. Together, these findings may help guide physicians in the prevention and treatment of infection after ACL reconstruction.

5 March 2025 in JMIR Cancer
Verified
Journal Article
Open access
AJAnna Rose Johnson
Anna Rose Johnson
GLGrace Anne Longfellow
Grace Anne Longfellow
CLClara N Lee
Clara N Lee
BOBenjamin Ormseth
Benjamin Ormseth
GSGary Skolnick
Gary Skolnick
TMTerence M. Myckatyn
Terence M. Myckatyn
Background: Decision aids improve patient and clinician decision-making but are underused and often restricted to clinical settings. Objective: Given limited studies analyzing the feasibility of disseminating decision aids through social media, this study aimed to evaluate the acceptability, trust, and engagement of women with social media as a tool to deliver online decision aids for cancer treatment. Methods: To prepare for potential dissemination of a breast cancer decision aid via social media, a cross-sectional survey in February 2023 was conducted via Prime Panels, an online market research platform, of women aged 35-75 years in the United States. Demographics, health, cancer information-seeking behaviors, social media use, trust in social media for health information, as well as the likelihood of viewing cancer-related health information and clicking on decision aids through social media, were assessed. Statistical analyses included descriptive statistics, correlations, and multivariable ordinal regression. Results: Of 607 respondents, 397 (65.4%) had searched for cancer information, with 185 (46.6%) using the internet as their primary source. Facebook (Meta) was the most popular platform (511/607, 84.2%). Trust in social media for health information was higher among Black (14/72, 19.4%) and Asian respondents (7/27, 25.9%) than among White respondents (49/480, 10.2%; P=.003). Younger respondents aged 35-39 years (17/82, 20.7%) showed higher trust than those aged 70-79 years (12/70, 17.1%; P<.001). Trust in social media for health information was linked to a higher likelihood of viewing cancer information and accessing a decision aid online (P<.001). Participants who rated social media as “Trustworthy” (n=73) were more likely to view cancer information (61/73, 83.6%) and click on decision aids (61/73, 83.6%) than those who found it “Untrustworthy” (n=277; view: 133/277, 48.0%; click: 125/277, 45.1%). Engagement with social media positively correlated with viewing online cancer information (Spearman ρ=0.20, P<.001) and willingness to use decision aids (ρ=0.21, P<.001). Multivariable ordinal regression analyses confirmed that perception of social media’s trustworthiness is a significant predictor of engagement with decision aids (untrustworthy vs trustworthy β=–1.826, P<.001; neutral vs trustworthy β=–0.926, P=.007) and of viewing cancer information (untrustworthy vs trustworthy β=–1.680, P<.001, neutral vs trustworthy β=–0.581, P=.098), while age and employment status were not significant predictors. Conclusions: This exploratory study suggests that social media platforms may increase access to health information and decision aids. No significant differences were observed between demographic variables and the use or trust in social media for health information. However, trust in social media emerged as a mediating factor between demographics and engagement with cancer information online. Before disseminating decision aids on social media, groups should identify existing trust and engagement patterns with different platforms within their target demographic.

5 October 2025 in JPRAS Open
Verified
Journal Article
Open access
PKPatrick J. Kennedy
Patrick J. Kennedy
MOMolly A. Olson
Molly A. Olson
IKIrina I. Kaptsan
Irina I. Kaptsan
JBJonathan Bernard
Jonathan Bernard
BOBen Ormseth
Ben Ormseth
JJJeffrey Janis
Jeffrey Janis
Obesity is a risk factor for diabetes mellitus (DM), which is associated with impaired wound healing and increased surgical site infections (SSI) due to poor vascularity. Patients who undergo abdominoplasties or panniculectomies often have multiple comorbidities, including DM and obesity. Previous research has demonstrated that adequate perioperative glycemic control is crucial to decreasing the risk of postoperative wound complications; however, the impact of diabetic pharmacology and HbA1c levels on postoperative outcomes in patients who undergo abdominoplasties or panniculectomies has not been studied. We conducted a retrospective cohort study on patients aged 18–85 who underwent abdominoplasty or panniculectomy at our institution from July 2014 to April 2023. Patients were stratified by HbA1c levels into four categories: Normal (<5.7), Prediabetic (5.7–6.4), Diabetic (6.5–6.9), and Diabetic with uncontrolled hyperglycemia (7.0–8.9). Diabetic patients were also categorized based on their diabetic medication use. Postoperative outcomes, including SSI, seroma, hematoma, readmission, and reoperation, were analyzed. Among the 594 patients, 16.3 % had DM, and 6.6 % were on anti-diabetic medications. SSIs occurred in 24.2 % of patients, with no significant differences between groups (p = 0.28). This study did not establish a clear relationship between diabetes medication regimens and poor postoperative outcomes; however, it highlights the medical complexity of patients who undergo abdominoplasty or panniculectomy and the perioperative glycemic management. Further research is needed to investigate how to better optimize diabetes management for improved surgical outcomes.

26 August 2026 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
AMAlexandra L. Martinez
Alexandra L. Martinez
BOBenjamin H. Ormseth
Benjamin H. Ormseth
ATAlexandra Thornton
Alexandra Thornton
JTJames F. Thornton
James F. Thornton


13 February 2026 in JMIR Cancer
Verified
Journal Article
Open access
AJAnna Rose Johnson
Anna Rose Johnson
GLGrace Anne Longfellow
Grace Anne Longfellow
CLClara N Lee
Clara N Lee
BOBenjamin Ormseth
Benjamin Ormseth
GSGary Skolnick
Gary Skolnick
TMTerence M. Myckatyn
Terence M. Myckatyn
[This corrects the article DOI: 10.2196/64724.].